Pages that link to "Q42023730"
Jump to navigation
Jump to search
The following pages link to Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma (Q42023730):
Displaying 9 items.
- CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA (Q24678824) (← links)
- Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer (Q35976947) (← links)
- Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer (Q36079626) (← links)
- Comparative study of CA242 and CA19-9 in chronic pancreatitis (Q39993160) (← links)
- Assessment of pancreatic duct strictures. (Q40512667) (← links)
- A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate d (Q41960323) (← links)
- Tumour-associated trypsin inhibitor in the diagnosis of pancreatic carcinoma (Q72526533) (← links)
- Nuclear magnetic resonance spectroscopy of plasma to distinguish between malignant and benign diseases causing jaundice and cholestasis (Q72842114) (← links)
- Evaluation of CA 242 as a tumor marker in gallbladder cancer (Q84107177) (← links)